PatientsVille.com Logo

PatientsVille

Supprelin Side Effects

Common Supprelin Side Effects


The most commonly reported Supprelin side effects (click to view or check a box to report):

Device Breakage (31)
Procedural Complication (24)
Mood Swings (10)
Implant Site Rash (8)
Implant Site Pain (8)
Breast Enlargement (8)
Headache (8)
Device Expulsion (5)
Hair Growth Abnormal (5)
Hypersensitivity (5)
Vomiting (5)
Growth Accelerated (4)
Abdominal Pain (4)
Fall (4)
Henoch-schonlein Purpura (4)
Implant Site Bruising (4)
Weight Increased (4)
Rash (4)
Dizziness (3)
Upper Limb Fracture (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Supprelin Side Effects Reported to FDA

The following Supprelin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Supprelin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Astrocytoma, Low Grade
This is a report of a 10-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Supprelin La (dosage: NA, start time: 200809), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Astrocytoma, Low Grade
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Supprelin La treatment in female patients, resulting in astrocytoma, low grade side effect.

Neurofibrosarcoma
This report suggests a potential Supprelin La Neurofibrosarcoma side effect(s) that can have serious consequences. A 11-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: precocious puberty and used Supprelin La (dosage: NA) starting Sep 27, 2012. Soon after starting Supprelin La the patient began experiencing various side effects, including:
  • Neurofibrosarcoma
Drugs used concurrently: NA. Although Supprelin La demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as neurofibrosarcoma, may still occur.

Device Extrusion
This Device Extrusion problem was reported by a pharmacist from US. A 9-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Aug 13, 2013 this consumer started treatment with Supprelin (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Supprelin, the patient experienced the following unwanted symptoms/side effects:
  • Device Extrusion
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as device extrusion, may become evident only after a product is in use by the general population.

Bipolar Disorder
This is a report of a 10-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: precocious puberty and was treated with Supprelin La (dosage: NA) starting Jun 20, 2013. Concurrently used drugs:
  • Buspar
  • Risperdal
  • Zyrtec
  • Miralax
  • Scopolamine
Soon after that, the consumer experienced the following side effects:
  • Bipolar Disorder
This opens a possibility that Supprelin La treatment could cause the above reactions, including bipolar disorder, and some female subjects may be more susceptible.


Astrocytoma, Low Grade, Condition Aggravated
A 8.-year-old female patient (weight: NA) from US with the following symptoms/conditions: precocious puberty started Supprelin La treatment (dosage: NA) on NS. Soon after starting Supprelin La treatment, the subject experienced various side effects, including:
  • Astrocytoma, Low Grade
  • Condition Aggravated
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Supprelin La.


A 11-year-old male patient from US (weight: NA) experienced symptoms, such as: precocious puberty and was treated with Supprelin La(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Supprelin La efficacy: NA.

    Intestinal Perforation, Volvulus, Acute Abdomen
    In this report, Supprelin La was administered for the following condition: NA.A 8.-year-old male consumer from US (weight: NA) started Supprelin La treatment (dosage: NA) on May 15, 2013.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Intestinal Perforation
    • Volvulus
    • Acute Abdomen
    A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Supprelin La treatment could be related to the listed above side effect(s).

    Liver Function Test Abnormal
    This is a report of the following Supprelin side effect(s):
    • Liver Function Test Abnormal
    A 10-year-old female patient from US (weight: NA) presented with the following condition: precocious puberty and received a treatment with Supprelin (dosage: NA) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Supprelin treatment could be associated with the listed above side effect(s).

    Scab, Breast Discolouration, Nipple Pain, Breast Pain
    This Supprelin La report was submitted by a 9.-year-old female consumer from US (weight: NA). The patient was diagnosed with: precocious puberty and Supprelin La was administered (dosage: NA) starting: Oct 19, 2011. The consumer developed a set of symptoms:
    • Scab
    • Breast Discolouration
    • Nipple Pain
    • Breast Pain
    Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Supprelin La treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Implant Site Rash, Rash Erythematous, Rash Pruritic, Feeling Abnormal, Hyperhidrosis
    This is a report of a possible correlation between Supprelin La use and the following symptoms/side effect(s):
    • Implant Site Rash
    • Rash Erythematous
    • Rash Pruritic
    • Feeling Abnormal
    • Hyperhidrosis
    which could contribute to an assessment of Supprelin La risk profile.A 11-year-old female consumer from US (weight: NA) was suffering from NA and was treated with Supprelin La (dosage: NA) starting Jan 23, 2013.Other concurrent medications: NA.

    Procedural Complication
    A 9.-year-old female patient from US (weight: NA) presented with the following symptoms: NA and after a treatment with Supprelin La (dosage: NA) experienced the following side effect(s):
    • Procedural Complication
    The treatment was started on Dec 04, 2012. Supprelin La was used in combination with the following drugs: NA.This report could alert potential Supprelin La consumers.

    Alopecia, Therapeutic Response Unexpected
    In this report, a female patient from US (weight: NA) was affected by a possible Supprelin La side effect.The patient was diagnosed with precocious puberty. After a treatment with Supprelin La (dosage: NA, start date: 201206), the patient experienced the following side effect(s):
    • Alopecia
    • Therapeutic Response Unexpected
    The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Supprelin La treatment.

    Hair Growth Abnormal, Breast Enlargement
    This is a report of a female patient from US (weight: NA), who used Supprelin La (dosage: NA) for a treatment of NA. After starting a treatment on 2011, the patient experienced the following side effect(s):
    • Hair Growth Abnormal
    • Breast Enlargement
    The following drugs could possibly have interacted with the Supprelin La treatment NA.Taken together, these observations suggest that a Supprelin La treatment could be related to side effect(s), such as Hair Growth Abnormal, Breast Enlargement.

    Implant Site Rash
    This implant site rash side effect was reported by a consumer or non-health professional from US. A 9-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Supprelin La (dosage: NA), which was started on 201209. Concurrently used drugs: NA. When starting to take Supprelin La the consumer reported the following symptoms:
    • Implant Site Rash
    These side effects may potentially be related to Supprelin La.

    Device Breakage, Procedural Complication
    This is a Supprelin La side effect report of a 10-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: precocious puberty,pharyngitis, who was treated with Supprelin La (dosage:NA, start time: Jan 11, 2010), combined with:
    • Pro-air
    • Multivitamins (1 Tablet)
    , and developed a serious reaction and a device breakage side effect. The patient presented with:
    • Device Breakage
    • Procedural Complication
    which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Supprelin La treatment in female patients suffering from precocious puberty,pharyngitis, resulting in device breakage.

    Growth Accelerated
    This report suggests a potential Supprelin La growth accelerated side effect(s) that can have serious consequences. A 8.-year-old female patient from US (weight:NA) was diagnosed with the following health condition(s): precocious puberty and used Supprelin La (dosage: NA) starting Sep 21, 2012. Soon after starting Supprelin La the patient began experiencing various side effects, including:
    • Growth Accelerated
    Drugs used concurrently:NA. Although Supprelin La demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as growth accelerated, may still occur.

    Growth Accelerated, Breast Enlargement
    This growth accelerated problem was reported by a physician from US. A 7-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On 201206 a consumer started treatment with Supprelin La (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Supprelin La, the patient experienced the following unwanted symptoms /side effects:
    • Growth Accelerated
    • Breast Enlargement
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as growth accelerated, may become evident only after a product is in use by the general population.

    Rash Erythematous
    This is a Supprelin La side effect report of a 6.-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Supprelin La (dosage: NA) starting Sep 05, 2012. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
    • Rash Erythematous
    This opens a possibility that Supprelin La could cause rash erythematous and that some female patients may be more susceptible.

    Injury, Implant Site Bruising
    A 6.-year-old female patient (weight: NA) from US with the following symptoms: precocious puberty started Supprelin La treatment (dosage: NA) on NS. Soon after starting Supprelin La treatment, the consumer experienced several side effects, including:
    • Injury
    • Implant Site Bruising
    . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Supprelin La side effects, such as injury.

    Application Site Dermatitis
    This application site dermatitis side effect was reported by a pharmacist from US. A 10-year-old male patient (weight:NA) experienced the following symptoms/conditions: precocious puberty.The patient was prescribed Supprelin La (dosage: NA), which was started on 201208. Concurrently used drugs: NA..When starting to take Supprelin La the consumer reported symptoms, such as:
    • Application Site Dermatitis
    These side effects may potentially be related to Supprelin La.

    Implant Site Rash
    This is a report of a 9.-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Supprelin La (dosage: NA, start time: Aug 01, 2012), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
    • Implant Site Rash
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Supprelin La treatment in female patients, resulting in implant site rash side effect.

    Procedural Complication, Device Breakage
    This report suggests a potential Supprelin La Procedural Complication, Device Breakage side effect(s) that can have serious consequences. A female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Supprelin La (dosage: NA) starting NS. Soon after starting Supprelin La the patient began experiencing various side effects, including:
    • Procedural Complication
    • Device Breakage
    Drugs used concurrently: NA. Although Supprelin La demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as procedural complication, may still occur.

    Device Breakage, Puberty, Procedural Complication, Weight Increased
    This Device Breakage, Puberty, Procedural Complication, Weight Increased problem was reported by a physician from US. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: precocious puberty. On 2010 this consumer started treatment with Supprelin La (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Supprelin La, the patient experienced the following unwanted symptoms/side effects:
    • Device Breakage
    • Puberty
    • Procedural Complication
    • Weight Increased
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as device breakage, may become evident only after a product is in use by the general population.

    Dizziness, Headache
    This is a report of a 9-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: precocious puberty,attention deficit/hyperactivity disorder,asthma and was treated with Supprelin La (dosage: NA) starting Nov 08, 2012. Concurrently used drugs:
    • Adderall (10 Mg)
    • Proair Inhaler (Unk)
    Soon after that, the consumer experienced the following side effects:
    • Dizziness
    • Headache
    This opens a possibility that Supprelin La treatment could cause the above reactions, including dizziness, and some female subjects may be more susceptible.

    Hypersensitivity
    A 10-year-old male patient (weight: NA) from US with the following symptoms/conditions: NA started Supprelin La treatment (dosage: NA) on Aug 07, 2012. Soon after starting Supprelin La treatment, the subject experienced various side effects, including:
    • Hypersensitivity
    Concurrently used drugs:
    • Abilify
    This finding indicates that some male patients could be more vulnerable to Supprelin La.

    1 of 6 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Supprelin Side Effects

    Did You Have a Supprelin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Supprelin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Supprelin Safety Alerts, Active Ingredients, Usage Information

    More About Supprelin

    Side Effects reported to FDA: 142

    Supprelin safety alerts: No

    Reported deaths: 6

    Reported hospitalizations: 9

    Latest Supprelin clinical trials

    Supprelin Reviews

    No reviews, be a first to report a side effect via side effect reporting form